Home > Boards > US Listed > Biotechs > INSMED (INSM)

Insmed DD summary

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
read_this_n0w Member Profile
 
Followed By 246
Posts 14,288
Boards Moderated 3
Alias Born 07/07/06
160x600 placeholder
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire (US) - 10/7/2019 4:05:00 PM
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire (US) - 9/5/2019 4:05:00 PM
Insmed to Present at Two September Conferences PR Newswire (US) - 9/3/2019 8:00:00 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 8/22/2019 4:12:42 PM
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire (US) - 8/2/2019 4:05:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/1/2019 7:34:21 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/1/2019 7:32:29 AM
Insmed Reports Second Quarter 2019 Financial Results and Provides Business Update PR Newswire (US) - 8/1/2019 7:30:00 AM
Insmed to Host Second Quarter 2019 Financial Results Conference Call on Thursday, August 1, 2019 PR Newswire (US) - 7/25/2019 8:00:00 AM
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire (US) - 7/2/2019 4:05:00 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 6/26/2019 4:50:53 PM
Insmed Announces Closing of Public Offering of Common Stock PR Newswire (US) - 6/26/2019 4:41:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 4:07:31 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/25/2019 10:23:45 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 6/12/2019 4:07:40 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/10/2019 4:07:06 PM
Insmed to Present at the Goldman Sachs 40th Annual Global Healthcare Conference PR Newswire (US) - 6/6/2019 8:00:00 AM
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire (US) - 6/4/2019 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/24/2019 11:36:43 AM
Insmed Announces Closing of Public Offering of Common Stock PR Newswire (US) - 5/24/2019 11:27:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/24/2019 6:05:46 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/23/2019 6:04:11 AM
Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) Edgar (US Regulatory) - 5/22/2019 6:03:11 AM
Insmed Announces Pricing of Public Offering of Common Stock PR Newswire (US) - 5/21/2019 8:56:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/20/2019 5:26:11 PM
read_this_n0w   Friday, 02/19/10 05:23:21 AM
Re: None
Post # of 6481 
Insmed DD summary

Chairman of the board Q3 conference call
direct audio file link: (20 minutes worth listening to)
http://home.xmsnet.nl/privatebanking/INSM/20091106_INSM_Q3_cc.mp3

Premacure and Insmed - retinopathy and more: (check commercial partners)
http://www.rop.gu.se/prevention/

Link from seekingalpha on Insmed no debt and 124mln cash position:
http://seekingalpha.com/article/172200-insmed-still-looks-very-undervalued?source=yahoo

Italian ALS data link:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=44055307

USA pals comments:(due to report on nov 30th to the fda and insmed on their experience with the IND use of iplex in ALS patient (small group of USA pals)
http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks_I/threadview?m=tm&bn=9585&tid=501758&mid=501758&tof=3&frt=1


Message board for Insmed is very active with a lot of innuendo and implicit lies, whilst short interest is low and institutuonal ownership grows.

Merck recently bought Avecia (old relation Insmed and Avecia dating back from 2002)
http://investor.insmed.com/releasedetail.cfm?ReleaseID=125217

Evidence letters from 2007 in strong support of IPLEX. various indications beyond scope of just MMD.
Direct court document pdfs.
http://www.investorvillage.com/smbd.asp?mb=235&mn=25724&pt=msg&mid=8459592

Bp3 and herceptine (just one example of multiple abstracts available, also much more recent)
http://www.investorvillage.com/smbd.asp?mb=235&mn=1793&pt=msg&mid=1172167


EU patent update january 2010(!)
Approved patent on purification will make igf1/igf1bp3 the domain of insmed.
Patent claim covers and applicable to accepted pharmaceutical salts.There is no way around this patent if one wants to achieve purity of higher than 80%. (insmed has 99%+ purity due to their processes)
https://register.epoline.org/espacenet/application;jsessionid=89FE32FD6D2FA04D1BA3B61CCD852467.RegisterPlus_prod_0?number=EP05854704&tab=main


Leaked Preliminary USA data on PALS , collected with fda set guidelines.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=46695692


"Compared to the normal relentless worsening in virtually all symptoms over any continuous 30-week period of time, the use of Iplex appears to have stabilized, if not improved, the condition of its users. Those using Iplex demonstrated an average improvement of symptoms of 9.3% (all symptoms combined) after the 30-week period.
"

Keep in mind ALS is a terminal illness

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist